Skip to main content

Table 1 Baseline characteristics (all-randomized set)

From: A double-blind, randomized, placebo-controlled trial studying the effects of Saccharomyces boulardii on the gastrointestinal tolerability, safety, and pharmacokinetics of miglustat

Characteristic Miglustat + S. boulardii then miglustat + placebo Miglustat + placebo then miglustat + S. boulardii All subjects
(n = 21) (n = 21) (N = 42)
Age, mean (SD) 39.6 (8.9) 35.8 (10.8) 37.7 (10.0)
Gender, n (%) male 11 (52) 8 (38) 19 (45)
Race, n (%):    
 Caucasian 12 (57) 8 (38) 20 (48)
 Black 4 (19) 11 (52) 15 (36)
 Asian 5 (24) 2 (10) 7 (17)
Mean weight, kg 72.7 71.7 72.2
BMI, mean (SD) kg/m2 25.5 (2.9) 25.4 (3.5) 25.4 (3.2)